A Decade of Translational Research Marked by an Anniversary Seminar
Our third and final seminar celebrating WCMTM’s 10-year anniversary brought together around 50 participants at Natrium. The event featured inspiring scientific presentations from our fellows, as well as insightful contributions from our partners at VGR and AstraZeneca.
WCMTM fellows presentations:
Aishe Sarshad | Reprogramming Nuclear RNA Interference to Mitigate Disease Progression
Daniel Bojar | A Sweet Life: Exploring glycobiology with AI
Leonardo de Assis | Exploring our Clock: The Relevance of the Circadian Clock for Precision Medicine
Göran Hilmersson, Dean at the Faculty of Science and Technology, highlighted Cross-faculty collaboration as at the heart of our work, with among other things AI-driven research that will further extend the reach of the basic sciences.
“New technologies are enabling the analysis of complex biological data and accelerating discoveries in diagnostics, drug development, and personalized medicine.” He said. “These advances are possible only through close collaboration and a shared commitment to innovation—by continuing to communicate, work together, and build strong bonds across disciplines, we can achieve even greater impact.”
Jenny Nyström, Dean at Sahlgrenska Academy, emphasized that having a centre for molecular and translational research like WCMTM not only unites many of the university’s excellentresearchers but also demonstrates the university’s active commitment to cutting-edge life science in collaboration with external partners.
“This fits perfectly within the vibrant life science region we’re part of,” she noted. “In Gothenburg, we have excellent conditions for collaboration — strong networks and short distances, both geographically and in terms of partnerships. I encourage all researchers, both senior and junior, to reach out, build strong connections, and explore the many resources available within and around the university.”
Jenny also highlighted the new Chalmers Sahlgrenska Health Engineering Alliance, as well as ongoing developments at GoCo Health Innovation City, where large and small biotech companies provide a dynamic forum for collaboration.
“The joint postdoctoral program between WCMTM and AstraZeneca is a great initiative,” she added. “I’ve taken part in it myself, and it was a valuable experience — both for advancing research and for creating chances for young researchers to explore a career path that bridges academy and industry”